SCHEMBL4336960

SCHEMBL4336960

CCOc1ccc(CC(OC(C)C)C(=O)O)cc1CCOC(=O)Nc1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
PPARG P37231 4/20 0.40
NPC1 O15118 3/20 0.39
CYP1A2 P05177 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MTNR1B P49286 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MTNR1A P48039 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
FPR2 P25090 3/20 0.38
PPARA Q07869 2/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4333076 0.93 LMNA (0.45) LMNATP53PPARGNPC1CYP1A2
SCHEMBL13810555 0.91 PPARG (0.41) LMNATP53PPARGNPC1CYP1A2
SCHEMBL4336402 0.91 PPARG (0.44) LMNATP53PPARGNPC1RAB9A
SCHEMBL4335108 0.90 L3MBTL1 (0.42) LMNAPPARGNPC1SMN1; SMN2ALDH1A1
SCHEMBL4332348 0.88 PPARA (0.49) PPARGPPARAPPARD
SCHEMBL4334936 0.86 PPARA (0.49) LMNATP53PPARGNPC1RAB9A
SCHEMBL4333413 0.86 BLM (0.42) LMNATP53PPARGRAB9ASMN1; SMN2
SCHEMBL13810562 0.85 PPARG (0.42) LMNATP53PPARGNPC1RAB9A
SCHEMBL4341195 0.85 PPARA (0.43) PPARGNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL4334226 0.85 NPSR1 (0.49) LMNATP53PPARGNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 LMNA 3790/4885TP53 4574/4885PPARG 379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.